Pain Neuroscience
Two people can have the same disc bulge on an MRI and live completely different lives: one barely notices it, the other cannot sit through a meal. Pain neuroscience explains why. Pain is not a direct readout of tissue damage but an output of the nervous system that weighs danger signals against everything else it knows, and understanding that process changes how we examine, treat and talk to people in pain.
By the end of this chapter you can
- Define pain and nociception, explain why they can occur without each other, and describe transduction, transmission, modulation and perception.
- Compare Aβ, Aδ and C fibers and trace the spinothalamic pathway from nociceptor to cortex.
- Distinguish nociceptive, neuropathic and nociplastic pain.
- Explain peripheral sensitization and central sensitization, including wind-up and the NMDA receptor, and define allodynia and hyperalgesia.
- Describe the gate control theory and the descending modulation system of the periaqueductal gray, rostral ventromedial medulla and locus coeruleus.
- Explain how endogenous opioids, placebo and nocebo effects and conditioned pain modulation alter pain.
- Apply the biopsychosocial model and the fear avoidance model to chronic pain.
- Use the principles of pain neuroscience education and avoid language that increases threat.
Section 1Nociception versus pain
Two different things
The International Association for the Study of Pain defines pain as an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage. Three words in that definition do a lot of work. Pain is an experience, so it happens in a person, not in a tissue. It is both sensory and emotional, so fear, mood and meaning are part of it from the start. And it is linked to potential damage, so pain can warn before harm occurs and can persist after harm has healed. The accompanying notes stress that pain is always personal, that it is shaped by biological, psychological and social factors, that pain and nociception are different, and that a person's report of pain should be respected.
Nociception is the neural process of encoding noxious stimuli: the activity of nociceptors and the pathways that carry their signals. Nociception is a source of input to the brain. Pain is one possible output. Most of the time they travel together: you touch a hot pan, nociceptors fire, and you feel pain. But each can occur without the other:
- Nociception without pain. Soldiers with severe wounds and athletes injured mid competition sometimes report little pain until the threat has passed. Physicians in the Second World War described wounded soldiers asking for far less pain relief than civilians with comparable surgical wounds, a difference attributed to the meaning of the injury (a ticket home rather than a disaster).
- Pain without nociception. Phantom limb pain is felt in a limb that no longer exists. A widely cited case report describes a builder in severe pain after a nail went through his boot, whose pain eased once the boot was removed and the nail was found to have passed between his toes. The brain had concluded "danger" from what it saw.
Rare genetic conditions show the value of pain. People born with congenital insensitivity to pain, often caused by loss of function mutations in the sodium channel Nav1.7, cannot feel pain. They suffer repeated unnoticed injuries, burns, fractures and joint destruction. Pain is a protective system, and the goal of care is to restore its accuracy rather than to switch it off.
The four processes
It helps to break the path from stimulus to experience into four steps.
- Transduction. A noxious stimulus (heat, intense pressure, chemicals) opens ion channels on the free nerve endings of nociceptors and creates a generator potential. Key transducers include TRPV1 (heat above about 43°C, acid and capsaicin, the active ingredient of chili peppers), TRPA1 (irritant chemicals), acid sensing ion channels and P2X3 receptors for ATP released from damaged cells. If the generator potential reaches threshold, voltage gated sodium channels (Nav1.7, Nav1.8 and Nav1.9 are concentrated in nociceptors) fire action potentials.
- Transmission. Action potentials travel along the primary afferent to the dorsal horn of the spinal cord, where the nociceptor releases glutamate and neuropeptides such as substance P and calcitonin gene related peptide (CGRP) onto second order neurons, which carry the signal to the brainstem and thalamus and on to the cortex.
- Modulation. At every relay, and especially in the dorsal horn, the signal is turned up or down by local interneurons and by pathways descending from the brain.
- Perception. The brain integrates the incoming signal with context, memory, attention, emotion and expectation, and the conscious experience of pain may or may not emerge.
The fibers and pathways
Nociceptors are the peripheral endings of two kinds of small fiber. Aδ fibers are thinly myelinated and fast; they produce first pain, the sharp, well localized prick that makes you pull your hand away. C fibers are unmyelinated and slow; they produce second pain, the dull, burning, poorly localized ache that follows a second or so later and lingers. Many C fibers are polymodal, responding to heat, pressure and chemicals. Some C fibers are normally unresponsive and "wake up" only in inflamed tissue; these are called silent or sleeping nociceptors. Large Aβ fibers carry touch, pressure and vibration and do not normally signal pain, but they matter for the gate control theory and for allodynia.
| Fiber | Myelin and diameter | Conduction velocity | Carries | Dorsal horn target |
|---|---|---|---|---|
| Aβ | Thick myelin, about 6 to 12 µm | About 35 to 75 m/s | Touch, pressure, vibration | Laminae III to V |
| Aδ | Thin myelin, about 1 to 5 µm | About 5 to 30 m/s | First (sharp) pain, cold | Laminae I and V |
| C | Unmyelinated, under about 1.5 µm | About 0.5 to 2 m/s | Second (burning, aching) pain, warmth, itch | Laminae I and II (substantia gelatinosa) |
In the dorsal horn, nociceptors synapse on two main types of projection neuron. Nociceptive specific neurons, concentrated in lamina I, respond only to noxious input. Wide dynamic range neurons, concentrated in lamina V, respond to a graded range of input from gentle touch to injury, and they receive convergent input from skin, muscle, joints and viscera, which is part of the basis of referred pain. Axons of the projection neurons cross the midline within a segment or two in the anterior white commissure and ascend in the anterolateral quadrant as the spinothalamic tract. A lateral division reaches the ventral posterolateral thalamus and then the primary and secondary somatosensory cortex, supporting the sensory discriminative features of pain (where, how strong, what kind). A medial division and related spinoreticular and spinoparabrachial pathways reach the brainstem, medial thalamus, amygdala and hypothalamus and from there the anterior cingulate and insular cortex, supporting the affective motivational features (how unpleasant, how urgent, what to do). Because the tract crosses early, a hemisection of the cord produces loss of pain and temperature on the opposite side below the lesion.
Brain imaging has not found a single pain center. Many regions activate together, including the somatosensory cortices, insula, anterior cingulate, prefrontal cortex, thalamus and amygdala, and the same regions are also active in other salient, threatening situations. This supports the view that pain is constructed by a distributed network (sometimes called the neuromatrix) that weighs evidence of danger.
Three mechanistic categories of pain
| Category | Definition | Typical features | Examples |
|---|---|---|---|
| Nociceptive | Pain from actual or threatened damage to non neural tissue, with activation of nociceptors | Localized, proportionate, clear mechanical aggravating and easing factors | Acute ankle sprain, facet joint strain, osteoarthritis flare |
| Neuropathic | Pain caused by a lesion or disease of the somatosensory nervous system | Burning, shooting, electric; in a nerve or root territory; numbness, allodynia | Radiculopathy, diabetic neuropathy, postherpetic neuralgia |
| Nociplastic | Pain from altered nociception without clear evidence of tissue damage or a lesion of the somatosensory system | Widespread or disproportionate, hypersensitivity to many stimuli, fatigue, poor sleep | Fibromyalgia, some chronic low back pain, irritable bowel syndrome |
These categories are not exclusive. A person with chronic low back pain may have a nociceptive contribution from a facet joint, a neuropathic contribution from a root and a nociplastic contribution from a sensitized nervous system, in proportions that change over time.
Pain is a personal sensory and emotional experience; nociception is the neural encoding of noxious stimuli. Nociceptors transduce stimuli, Aδ and C fibers transmit them to the dorsal horn, the spinothalamic tract carries them to a distributed brain network, and the signal is modulated at every step. Pain can be nociceptive, neuropathic or nociplastic, often in combination.
Section 2Peripheral and central sensitization
A system that learns
The nociceptive system is not a fixed set of wires. After injury its sensitivity rises, so that stimuli that were harmless now hurt and stimuli that hurt now hurt more. This sensitization is normally helpful: an inflamed ankle that hurts when you lean on it encourages you to protect it while it heals. Sensitization usually fades as tissue recovers. When it persists or spreads, it becomes a major driver of chronic pain. Two terms describe what patients feel:
- Allodynia is pain from a stimulus that does not normally provoke pain, such as light touch of clothing on sunburned skin.
- Hyperalgesia is increased pain from a stimulus that is normally painful, such as a pinprick that feels unusually sharp. Primary hyperalgesia occurs in the injured tissue itself; secondary hyperalgesia occurs in the surrounding uninjured tissue and reflects changes in the spinal cord.
Peripheral sensitization
When tissue is injured, damaged cells, platelets, mast cells and immune cells release a mixture of chemicals often called the inflammatory soup: bradykinin, prostaglandins (especially PGE2), histamine, serotonin, ATP, hydrogen ions, nerve growth factor (NGF) and cytokines such as tumor necrosis factor alpha and interleukins 1β and 6. Some of these activate nociceptors directly (bradykinin, ATP, acid). Others sensitize them. Prostaglandins and NGF trigger intracellular signaling (protein kinases A and C) that phosphorylates TRPV1 and sodium channels, lowering their thresholds and increasing their firing. NGF also travels back to the cell body in the dorsal root ganglion and increases the production of channels and neuropeptides. Silent nociceptors are recruited. The net result is primary hyperalgesia and tenderness at the site of injury.
Activated nociceptors also act in reverse. Impulses spread along branches of the same nerve ending and release substance P and CGRP into the tissue, causing vasodilation, leaky vessels, swelling and mast cell degranulation. This neurogenic inflammation produces the red flare around a scratch and helps explain why nerve activity itself can sustain inflammation. Nonsteroidal anti-inflammatory drugs work largely by blocking cyclooxygenase and the prostaglandins it makes; ice, compression and relative rest reduce the inflammatory drive; and topical capsaicin, which overstimulates and then defunctionalizes TRPV1 bearing endings, shows how the peripheral terminal can be targeted directly.
Central sensitization
Central sensitization is an increase in the responsiveness of nociceptive neurons in the central nervous system to their normal or subthreshold input. It was first described in the dorsal horn in the early 1980s and is now recognized at several levels of the neuraxis. Several mechanisms contribute:
- Wind-up and NMDA receptors. Glutamate released by nociceptors acts on AMPA receptors for fast transmission. The NMDA receptor is normally blocked by a magnesium ion. Repeated C fiber input, together with substance P and CGRP, depolarizes the dorsal horn neuron enough to expel the magnesium. Calcium then flows in and activates kinases that make the neuron more excitable. In wind-up, repeated identical C fiber stimuli at a rate of about one per second or faster produce a progressively larger response; the perceptual counterpart is temporal summation, in which repeated identical pinpricks feel increasingly painful.
- Long term potentiation. Intense input can strengthen dorsal horn synapses for hours to days, a form of pain memory that resembles learning in the hippocampus.
- Receptive field expansion. Sensitized neurons respond to input from a larger area, so pain and tenderness spread beyond the injured tissue (secondary hyperalgesia).
- Disinhibition. Inhibitory interneurons that release GABA and glycine become less effective after nerve injury, so the brakes on transmission weaken. Aβ touch fibers can then access pain pathways, producing allodynia.
- Glial activation. Microglia and astrocytes in the spinal cord respond to injury by releasing cytokines and brain derived neurotrophic factor, which amplify neuronal excitability. Glia are now seen as active partners in persistent pain.
- Descending facilitation. Brainstem pathways can turn the dorsal horn up as well as down (see Section 3). Stress, poor sleep and threat can tip the balance toward facilitation.
| Feature | Peripheral sensitization | Central sensitization |
|---|---|---|
| Where | Nociceptor terminals in the tissue | Dorsal horn, brainstem, thalamus and cortex |
| Main drivers | Inflammatory mediators: prostaglandins, bradykinin, NGF, cytokines | Glutamate and NMDA receptors, neuropeptides, loss of inhibition, glia, descending facilitation |
| Clinical sign | Primary hyperalgesia; tenderness limited to the injured area | Secondary hyperalgesia, allodynia, spreading or widespread pain, temporal summation |
| Relationship to tissue | Closely tied to tissue state; settles as inflammation resolves | Can persist after tissue heals; pain may be disproportionate to findings |
| Typical treatment targets | Anti-inflammatory measures, protection, graded loading | Education, graded activity, sleep, stress management, centrally acting medicines |
Recognizing a sensitized nervous system
No single test proves central sensitization in a patient, and the term is sometimes used too loosely as a label for any pain that is hard to explain. Clinicians look for a pattern: pain that is disproportionate to the nature and extent of injury; pain that is widespread or spreading; hypersensitivity to many stimuli including pressure, cold, light, sound and smell; pain that is unpredictable or poorly related to mechanical loading; and associated fatigue, poor sleep, low mood and difficulty concentrating. Research tools include pressure pain thresholds measured at sites far from the painful area, temporal summation protocols and tests of conditioned pain modulation. Recognizing this pattern does not mean the pain is "not real" or "all in the head." It means the nervous system has become more protective, and treatment should target that system as well as any local tissue.
Sensitization raises the gain of the nociceptive system. Peripheral sensitization occurs at nociceptor terminals through inflammatory mediators and causes primary hyperalgesia. Central sensitization occurs in the cord and brain through NMDA receptor activation, wind-up, long term potentiation, disinhibition, glial activation and descending facilitation, causing allodynia, secondary hyperalgesia and spreading pain that can outlast tissue healing.
Section 3The gate control theory and descending modulation
The gate control theory
Before the 1960s, pain was often taught as a simple specificity model: pain receptors connect to a pain pathway that connects to a pain center, like a bell rope, so the amount of pain should match the amount of damage. Clinical experience did not fit. Pain could be blocked by distraction and intensified by fear, and rubbing a bumped elbow helped. In 1965 the psychologist Ronald Melzack and the neuroscientist Patrick Wall proposed the gate control theory, which placed a modulating mechanism in the dorsal horn of the spinal cord.
The theory has four elements. Large diameter fibers (Aβ, carrying touch and vibration) and small diameter fibers (Aδ and C, carrying nociceptive signals) both excite transmission (T) cells that project to the brain. Both fiber types also connect to inhibitory interneurons in the substantia gelatinosa (SG, lamina II). Large fiber input excites these interneurons, which inhibit transmission and "close the gate." Small fiber input inhibits the interneurons, which "opens the gate." The fourth element is central control: pathways descending from the brain can open or close the gate according to attention, emotion and past experience. Pain depends on the balance of these inputs, not on the nociceptive signal alone.
Later research showed that the specific wiring Melzack and Wall drew was too simple. Inhibition in the dorsal horn involves many interneuron types acting both before and after the synapse, and the substantia gelatinosa contains excitatory as well as inhibitory neurons. But the central ideas proved durable: the spinal cord is an active processor, not a relay; touch input can reduce pain transmission; and the brain can reach down to control what reaches it. The theory explains why rubbing an injury, applying vibration or using transcutaneous electrical nerve stimulation (TENS) can ease pain, and it opened the door to treating pain through the nervous system as well as the tissues. Melzack later extended these ideas in the neuromatrix theory, which describes pain as an output of a widely distributed brain network shaped by genetics and experience.
The descending modulation system
In 1969 a striking experiment showed that electrical stimulation of the periaqueductal gray (PAG) in the midbrain of rats produced enough analgesia to allow abdominal surgery without anesthesia. This stimulation produced analgesia led to the discovery of the body's own pain control system and, in the 1970s, of opioid receptors and the endogenous opioids: enkephalins, β-endorphin and dynorphins.
The descending system works as a chain. Higher centers, including the prefrontal cortex, anterior cingulate, amygdala and hypothalamus, project to the PAG. The PAG projects to the rostral ventromedial medulla (RVM), which includes the serotonin rich nucleus raphe magnus. The RVM sends axons down the dorsolateral funiculus to the dorsal horn. A parallel noradrenergic pathway descends from the locus coeruleus and nearby nuclei in the pons. In the dorsal horn, serotonin and norepinephrine (acting largely through α2 adrenergic receptors) inhibit transmission directly and by activating local inhibitory interneurons that release enkephalin and GABA. Opioids act presynaptically, closing calcium channels so that nociceptor terminals release less glutamate and substance P, and postsynaptically, opening potassium channels that hyperpolarize the projection neuron.
This system is bidirectional. The RVM contains OFF cells, which inhibit nociceptive transmission, and ON cells, which facilitate it. In acute danger the system usually inhibits pain so that the animal can escape (stress induced analgesia). In persistent pain, after nerve injury, with chronic stress or poor sleep, the balance can shift toward descending facilitation, keeping the dorsal horn sensitized.
Everyday modulators of pain
- Conditioned pain modulation. A painful stimulus in one part of the body reduces pain elsewhere, a phenomenon studied in animals as diffuse noxious inhibitory controls. In the lab it is tested by measuring a pain threshold before and during immersion of the other hand in cold water. Many people with chronic pain conditions show weaker conditioned pain modulation, consistent with a shift away from descending inhibition.
- Placebo analgesia. Expecting relief can produce real, measurable relief. Part of this effect is blocked by naloxone, an opioid antagonist, showing that expectation can release endogenous opioids; other parts involve endocannabinoids and dopamine reward circuits. Brain imaging shows reduced activity in pain responsive regions during placebo analgesia.
- Nocebo hyperalgesia. Expecting harm or more pain can increase pain. Anxiety triggers the release of cholecystokinin, which counteracts opioid analgesia and facilitates pain. Warnings delivered in frightening language, labels that suggest damage and anxious body language can all act as nocebos.
- Attention, mood and sleep. Distraction reduces pain, while hypervigilance increases it. Low mood, anxiety and poor sleep amplify pain; one night of sleep restriction lowers pain thresholds the next day.
- Exercise. A single bout of exercise often produces short lived hypoalgesia in healthy people (exercise induced hypoalgesia), although the effect can be weaker or absent in some chronic pain conditions, which is one reason graded, tolerable exercise works better than a sudden large dose.
| Modulator | Where it acts | Effect on pain | Related treatment |
|---|---|---|---|
| Endogenous opioids (enkephalins, β-endorphin, dynorphins) | PAG, RVM, dorsal horn, peripheral terminals | Inhibit transmission (μ, δ, κ receptors) | Opioid medicines; part of placebo analgesia |
| Serotonin | RVM to dorsal horn | Mostly inhibits; some receptor subtypes facilitate | SNRIs, tricyclic antidepressants |
| Norepinephrine | Locus coeruleus to dorsal horn (α2 receptors) | Inhibits | SNRIs such as duloxetine; clonidine |
| GABA and glycine | Dorsal horn interneurons | Inhibit; loss contributes to allodynia | Some antispasticity and anticonvulsant drugs |
| Endocannabinoids | PAG, dorsal horn, peripheral terminals | Inhibit | Cannabinoid medicines (evidence mixed) |
| Cholecystokinin | Brainstem and cord | Facilitates; opposes opioids | Target in nocebo research |
Manual therapies, including spinal manipulation and mobilization, have been studied for neurophysiological effects of this kind. Laboratory studies report short term changes after manipulation such as raised pressure pain thresholds and reduced temporal summation, which some researchers interpret as engagement of spinal and descending inhibitory mechanisms. These findings are interesting but come mostly from small studies with short follow up, and they do not establish that such effects explain the clinical benefits seen in trials. Similar short term hypoalgesia follows exercise, touch and other interventions, so the effects are probably not specific to any one technique.
The gate control theory showed that pain is modulated in the dorsal horn: large fiber input and descending control close the gate, small fiber input opens it. The descending system runs from higher brain centers to the PAG, RVM and locus coeruleus and down to the dorsal horn, using opioids, serotonin and norepinephrine. It can inhibit or facilitate pain, and it underlies placebo, nocebo, stress and conditioned pain modulation effects.
Section 4Chronic pain and the biopsychosocial model
When pain persists
Chronic pain is pain that persists or recurs for longer than three months. The time frame is practical rather than biological: most tissues have passed through the inflammatory and proliferative phases of healing by then, so pain that continues usually reflects more than ongoing tissue damage. Chronic pain is common and costly. Large national surveys in the United States estimate that about one in five adults has chronic pain, and that roughly 7 to 8 percent have high impact chronic pain that limits life or work activities on most days. Low back pain is the leading cause of years lived with disability worldwide, and neck pain is not far behind.
The current international classification of diseases divides chronic pain into two groups. Chronic primary pain is pain in one or more regions that is associated with significant emotional distress or functional disability and is not better explained by another condition; examples include fibromyalgia, chronic primary low back pain and irritable bowel syndrome. Chronic secondary pain is linked to another disease as its underlying cause, such as cancer, surgery or trauma, a nerve lesion, a headache disorder, a visceral disease or musculoskeletal disease such as osteoarthritis. In the primary category, pain is regarded as a condition in its own right rather than only a symptom.
The biopsychosocial model
In 1977 the psychiatrist George Engel argued that the dominant biomedical model, which explains illness entirely by measurable biological deviation, could not account for why people with the same pathology suffer so differently. He proposed the biopsychosocial model, in which biological, psychological and social factors interact to shape health and illness. Pain is the clearest example. The model does not say pain is psychological; it says that every pain has biological, psychological and social dimensions, and that the weight of each varies between people and over time. It also does not dismiss biology. A fracture is still a fracture. The point is that treating only the tissue often fails when other factors are keeping the pain system on alert.
| Domain | Factors linked to worse outcomes | Protective factors |
|---|---|---|
| Biological | Severe initial pain, nerve injury, central sensitization, poor sleep, other chronic diseases, physical deconditioning, genetic variation in pain processing | Good general health and fitness, regular physical activity, adequate sleep |
| Psychological | Pain catastrophizing, fear of movement (kinesiophobia), depression, anxiety, low self efficacy, negative expectations of recovery, past trauma | Confidence in coping, positive recovery expectations, acceptance, active coping strategies |
| Social | Job dissatisfaction, heavy physical work without modified duties, disputes over compensation, social isolation, financial stress, adverse childhood experiences | Supportive family and workplace, modified duties, clear and consistent messages from clinicians |
Pain catastrophizing deserves special attention. It is a set of exaggerated negative thoughts about pain with three components: rumination (being unable to stop thinking about it), magnification (worrying that something serious is happening) and helplessness (feeling nothing can be done). Catastrophizing is measured with questionnaires and is one of the most consistent predictors of pain intensity, disability and poor recovery after injury and surgery. It is not a character flaw. It is a learned response to threat that can be changed.
The fear avoidance model
The fear avoidance model describes how an episode of acute pain can lead either to recovery or to a self sustaining cycle of disability. After an injury, a person who interprets the pain as manageable and not dangerous continues to move, gradually resumes activity and recovers. A person who catastrophizes about the pain develops fear of pain and of movement, avoids activities believed to be harmful and becomes hypervigilant to bodily sensations. Avoidance prevents the person from learning that movement is safe, leads to deconditioning and loss of valued roles, and feeds low mood and disability, all of which make pain more likely to persist. Each turn of the cycle strengthens the next.
What changes in chronic pain
Persistent pain is accompanied by changes across the nervous system. In the spinal cord, the mechanisms of central sensitization described in Section 2 may persist. In the brain, imaging studies report altered activity and connectivity, with a relative shift in some people from sensory regions toward emotional and learning circuits involving the prefrontal cortex, nucleus accumbens and amygdala as pain becomes chronic. Some studies report altered body maps in the somatosensory cortex and reduced precision in sensing the painful body part, as well as reductions in gray matter in specific regions; several of these changes partially reverse when pain is successfully treated. These findings must be interpreted carefully: they come largely from group averages, they do not diagnose individual patients, and they do not show permanent damage. They do show that chronic pain involves a changed nervous system, which is a reason for hope because nervous systems keep changing.
The motor system adapts too. People in pain often move differently: they brace, guard, move more slowly and co-contract trunk muscles. In the short term this protects injured tissue. In the long term it can increase load, reduce variability of movement and become a habit that persists after the original reason has gone.
Treatment that matches the model
Because chronic pain has several drivers, single treatments rarely solve it. Clinical guidelines for chronic low back pain consistently recommend nonpharmacological care first: education and reassurance, exercise therapy, and psychologically informed approaches such as cognitive behavioral therapy, acceptance and commitment therapy and mindfulness based programs. Many guidelines also list spinal manipulation, massage, acupuncture, yoga and tai chi as options, generally with small to moderate effects. Multidisciplinary rehabilitation, combining physical, psychological and workplace elements, helps patients with more severe disability. Medicines play a supporting role. Nonsteroidal anti-inflammatory drugs have small effects for back pain; duloxetine is an option for some patients; and opioids are not recommended as first line treatment for chronic noncancer pain because their long term benefits are small and their risks, including dependence, overdose and opioid induced hyperalgesia, are significant.
Graded approaches put the fear avoidance model into practice. In graded activity, the patient and clinician set a baseline for a valued activity and increase it on a planned schedule regardless of day to day pain fluctuations. In graded exposure, the patient builds a hierarchy of feared movements (perhaps bending to lift a laundry basket) and confronts them step by step, so that expectations of harm are tested and corrected. Pacing helps people who swing between overactivity on good days and collapse on bad days to spread activity more evenly.
Chronic pain lasts beyond three months and affects about one adult in five. The biopsychosocial model holds that biological, psychological and social factors all shape pain and disability. Catastrophizing and fear of movement drive the fear avoidance cycle, while low threat appraisals lead to recovery. Effective care combines education, graded exercise and activity, psychological approaches and selective use of medicines, with opioids not first line.
Section 5Explaining pain to patients
Why explanation is treatment
Every patient arrives with an explanation for their pain, whether or not they say it aloud: "my disc has slipped," "my spine is crumbling," "something is out of place," "I must have done serious damage." These beliefs matter because the brain uses them as evidence when it decides how much danger the body is in. A frightening explanation can increase threat, fear, guarding and pain; an accurate, reassuring explanation can reduce them. For this reason, explaining pain is not a courtesy before treatment begins. It is part of the treatment.
Pain neuroscience education (also called therapeutic neuroscience education) is a structured approach to teaching people about the biology of pain, developed by clinicians and researchers from the late 1990s onward. Its goal is reconceptualization: helping a person shift from understanding pain as a measure of tissue damage to understanding it as a protective output of the nervous system that can become overprotective, and that can be retrained. Typical core messages are:
- Pain is real, and it is produced by the brain in every case, including after an obvious injury.
- Pain is a protector. It depends on how much danger the brain perceives, not on how much damage there is.
- Hurt does not always mean harm. After the first few weeks, pain is a poor guide to the state of the tissues.
- The nervous system can become more sensitive over time, like a car alarm that goes off when someone walks past.
- Many things affect the alarm: sleep, stress, mood, beliefs, fitness, the context of movement and the words people hear.
- The system can change. Gradual, safe exposure to movement and activity teaches it to be less protective.
Metaphors and tools that help
Metaphors carry complex ideas quickly and stick in memory. Common examples include the oversensitive alarm system; a volume knob that can be turned up or down by the brain; the protectometer, a gauge whose needle is pushed toward protection by "danger in me" (DIMs) and toward relaxation by "safety in me" (SIMs); and the idea that tissues are like a garden that grows back stronger with sensible loading. Simple drawings of the nervous system, a list of the patient's own DIMs and SIMs, and stories of others who recovered can make the ideas personal.
Explanation works best as a conversation rather than a lecture. Begin by asking what the person believes is wrong and what worries them most. Validate the pain as real. Give a small number of key messages in plain language. Check understanding with teach back ("Can you tell me in your own words what we talked about?"). Link the explanation immediately to action, so that understanding becomes a reason to move, sleep, pace and return to valued activities. Pay attention to health literacy, culture and the person's own goals.
The words we use
Clinicians' words have power, and some common phrases act as nocebos. Describing a spine as "degenerated," a disc as "slipped" or a joint as "bone on bone," or telling a patient never to bend again, can increase fear and disability even when meant kindly. Many of these phrases describe imaging findings that are common in people without pain. The table offers alternatives that are accurate and less threatening.
| Phrase that raises threat | Why it hurts | Accurate, less threatening alternative |
|---|---|---|
| "Your spine is degenerating." | Implies an inevitable decline | "These are normal age changes, like wrinkles on the inside. They are common in people without pain." |
| "You have a slipped disc." | Discs do not slip; suggests something is out of place and fragile | "A disc is irritating a nerve. Most of these settle well, and the body often reabsorbs the bulge." |
| "Your back is out" or "your hip is out of alignment." | Suggests the body is unstable and needs fixing by someone else | "Your back is sensitive and guarded right now. Movement will help it settle." |
| "Be careful; avoid bending and lifting." | Teaches avoidance and fear of movement | "Your back is strong. Let's build up bending and lifting step by step." |
| "This is chronic; you will have to learn to live with it." | Removes hope | "Pain systems can change. People improve even after years of pain." |
| "Your pain is all in your head." | Dismisses the pain as imagined | "Your pain is real. Your nervous system has become extra protective, and we can work on that." |
Imaging findings in people without pain
One of the most useful facts for explaining back pain is how often imaging shows "abnormal" findings in people who have no pain at all. A large systematic review of MRI and CT studies in people without back pain found that disc degeneration and disc bulges are common from early adulthood and become the norm with age. Findings such as disc protrusions, annular fissures and facet degeneration are also common. This is why guidelines advise against routine imaging for low back pain without red flags: it rarely changes management, and labels from the report can increase fear, prompt more procedures and slow recovery.
Does pain education work?
Randomized trials and systematic reviews suggest that pain neuroscience education produces small to moderate short term improvements in pain, disability, catastrophizing and fear of movement in people with chronic musculoskeletal pain. Effects are larger and more lasting when education is combined with active treatment such as exercise or graded activity, and smaller when education is given alone. Education is not a replacement for movement; it is a way to make movement feel safe enough to do. Some patients find the message hard to accept at first, especially if it sounds like their pain is being dismissed, which is why validation and careful wording matter.
Several related approaches build on the same ideas. Cognitive functional therapy combines individualized explanation with guided exposure to feared movements and changes in protective movement habits; a large trial reported meaningful and sustained improvements in disability for people with chronic low back pain. Pain reprocessing therapy teaches patients to reappraise pain as safe and to approach sensations with curiosity rather than fear; an early trial reported that many participants became pain free or nearly so, though the findings need replication. Across approaches, the common thread is that changing what pain means to a person can change how much it hurts and how much it limits life.
Explaining pain in manual and holistic care
Manual therapists, including chiropractors, osteopaths and physical therapists, spend a great deal of time with patients in pain and have many chances to shape their beliefs. Historically, some explanations in these professions emphasized structural ideas such as bones "out of place," misalignment or instability. Contemporary education across the manual therapy professions increasingly favors explanations that are accurate to current neuroscience: hands-on treatment as a way to reduce sensitivity and protective muscle activity in the short term, open a window for movement and build confidence, rather than as a way to put something back in place. This framing respects the experience of patients who feel better after treatment while avoiding messages that create dependence or fear. Holistic practices such as yoga, tai chi, meditation and breathing training fit naturally with pain neuroscience because they work directly with attention, threat appraisal, stress physiology and confident movement, and several have modest supporting evidence for chronic low back pain.
Explaining pain is part of treatment. Pain neuroscience education helps people understand pain as a protective, changeable output of the nervous system rather than a measure of damage. Use plain language, metaphors and teach back, avoid nocebo phrases, remember that imaging findings are common in people without pain, and pair education with graded movement for the best effect.
The chapter in one breath
- Pain is an unpleasant sensory and emotional experience; nociception is neural encoding of noxious stimuli, and each can occur without the other.
- Nociception involves transduction, transmission, modulation and perception; Aδ fibers carry first pain and C fibers second pain.
- The spinothalamic tract crosses near its level of entry and feeds a distributed brain network; there is no single pain center.
- Pain mechanisms are nociceptive, neuropathic or nociplastic, often mixed.
- Peripheral sensitization from inflammatory mediators lowers nociceptor thresholds and causes primary hyperalgesia.
- Central sensitization involves NMDA receptors, wind-up, disinhibition, glia and descending facilitation and causes allodynia and secondary hyperalgesia.
- The gate control theory holds that large fiber input and descending control close a dorsal horn gate that small fiber input opens.
- The descending system (PAG, RVM, locus coeruleus) uses endogenous opioids, serotonin and norepinephrine to inhibit or facilitate pain and underlies placebo and nocebo effects.
- Chronic pain lasts beyond three months and is best understood through the biopsychosocial model.
- Catastrophizing and fear drive the fear avoidance cycle; low threat appraisals and graded exposure lead to recovery.
- Pain neuroscience education works best combined with exercise; avoid nocebo language and remember that imaging findings are common in people without pain.
Words worth knowing
| Term | What it means |
|---|---|
| Pain | An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage. |
| Nociception | Neural process of encoding noxious stimuli by nociceptors and their pathways. |
| Nociceptor | Sensory neuron ending that responds to potentially damaging stimuli. |
| A delta fiber | Thinly myelinated fast fiber carrying sharp first pain. |
| C fiber | Unmyelinated slow fiber carrying dull, burning second pain. |
| TRPV1 | Ion channel on nociceptors activated by heat, acid and capsaicin. |
| Wide dynamic range neuron | Dorsal horn neuron responding to touch through to noxious input, with convergent inputs. |
| Spinothalamic tract | Crossed ascending pathway carrying pain and temperature to the thalamus. |
| Neuropathic pain | Pain caused by a lesion or disease of the somatosensory nervous system. |
| Nociplastic pain | Pain from altered nociception without clear tissue damage or nerve lesion. |
| Allodynia | Pain from a stimulus that is not normally painful. |
| Hyperalgesia | Increased pain from a stimulus that is normally painful. |
| Peripheral sensitization | Lowered threshold and increased responsiveness of nociceptor terminals, usually from inflammation. |
| Central sensitization | Increased responsiveness of central nociceptive neurons to normal or subthreshold input. |
| Wind-up | Progressive increase in dorsal horn response to repeated identical C fiber input. |
| NMDA receptor | Glutamate receptor, blocked by magnesium at rest, that drives central sensitization when opened. |
| Neurogenic inflammation | Inflammation caused by nociceptors releasing substance P and CGRP into tissue. |
| Gate control theory | Theory that dorsal horn circuits, set by large fiber, small fiber and descending input, control pain transmission. |
| Periaqueductal gray | Midbrain region that drives descending pain inhibition, rich in opioid receptors. |
| Rostral ventromedial medulla | Brainstem relay with ON and OFF cells that facilitate or inhibit dorsal horn transmission. |
| Conditioned pain modulation | Reduction of pain in one area by a painful stimulus elsewhere. |
| Nocebo | Worsening of symptoms caused by negative expectations or threatening messages. |
| Chronic pain | Pain that persists or recurs for more than three months. |
| Biopsychosocial model | Framework in which biological, psychological and social factors interact to shape illness. |
| Pain catastrophizing | Exaggerated negative thinking about pain: rumination, magnification and helplessness. |
| Kinesiophobia | Excessive fear of movement because of fear of pain or reinjury. |
| Graded exposure | Stepwise confrontation of feared movements to correct expectations of harm. |
| Pain neuroscience education | Teaching the biology of pain to reframe it as a changeable protective output. |